19-3885803-C-T

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_ModerateBP6BP7BS2

The NM_033064.5(ATCAY):​c.36C>T​(p.Asn12Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000646 in 1,552,240 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00058 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00065 ( 3 hom. )

Consequence

ATCAY
NM_033064.5 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: -2.00

Publications

2 publications found
Variant links:
Genes affected
ATCAY (HGNC:779): (ATCAY kinesin light chain interacting caytaxin) This gene encodes a neuron-restricted protein that contains a CRAL-TRIO motif common to proteins that bind small lipophilic molecules. Mutations in this gene are associated with cerebellar ataxia, Cayman type. [provided by RefSeq, Jul 2008]
ATCAY Gene-Disease associations (from GenCC):
  • cerebellar ataxia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Cayman type cerebellar ataxia
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant 19-3885803-C-T is Benign according to our data. Variant chr19-3885803-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 328984.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=2}.
BP7
Synonymous conserved (PhyloP=-2 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATCAYNM_033064.5 linkc.36C>T p.Asn12Asn synonymous_variant Exon 2 of 13 ENST00000450849.7 NP_149053.1 Q86WG3-1A0A0S2Z5T8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATCAYENST00000450849.7 linkc.36C>T p.Asn12Asn synonymous_variant Exon 2 of 13 1 NM_033064.5 ENSP00000390941.1 Q86WG3-1

Frequencies

GnomAD3 genomes
AF:
0.000585
AC:
89
AN:
152112
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00184
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000720
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.000565
AC:
89
AN:
157478
AF XY:
0.000541
show subpopulations
Gnomad AFR exome
AF:
0.000122
Gnomad AMR exome
AF:
0.00129
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000648
Gnomad NFE exome
AF:
0.000691
Gnomad OTH exome
AF:
0.00180
GnomAD4 exome
AF:
0.000653
AC:
914
AN:
1400010
Hom.:
3
Cov.:
31
AF XY:
0.000599
AC XY:
414
AN XY:
690590
show subpopulations
African (AFR)
AF:
0.0000949
AC:
3
AN:
31600
American (AMR)
AF:
0.00173
AC:
62
AN:
35790
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25192
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35762
South Asian (SAS)
AF:
0.000278
AC:
22
AN:
79228
European-Finnish (FIN)
AF:
0.000142
AC:
7
AN:
49390
Middle Eastern (MID)
AF:
0.00131
AC:
7
AN:
5342
European-Non Finnish (NFE)
AF:
0.000712
AC:
769
AN:
1079624
Other (OTH)
AF:
0.000758
AC:
44
AN:
58082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
49
98
146
195
244
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000585
AC:
89
AN:
152230
Hom.:
0
Cov.:
31
AF XY:
0.000672
AC XY:
50
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.0000481
AC:
2
AN:
41554
American (AMR)
AF:
0.00183
AC:
28
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4828
European-Finnish (FIN)
AF:
0.0000943
AC:
1
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000720
AC:
49
AN:
68012
Other (OTH)
AF:
0.00331
AC:
7
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000469
Hom.:
0
Bravo
AF:
0.000740

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ATCAY: BP4, BP7 -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cayman type cerebellar ataxia Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.32
CADD
Benign
3.8
DANN
Benign
0.78
PhyloP100
-2.0
PromoterAI
-0.0087
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs368213837; hg19: chr19-3885801; COSMIC: COSV56654126; API